Hepatotoxicity of contemporary antiretroviral drugs.

Author: OttoAshley O, RiveraChristina G, TemesgenZelalem, ZeuliJohn D

Paper Details 
Original Abstract of the Article :
To date, more than 30 antiretroviral drugs have been approved by the Food and Drug Administration for the treatment of HIV infection. As new drugs with better efficacy and safety profile become available for clinical practice, older drugs are either withdrawn from the market or become no longer acti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/34545037

データ提供:米国国立医学図書館(NLM)

Hepatotoxicity of Antiretroviral Drugs: Navigating the Shifting Sands of HIV Treatment

The development of antiretroviral therapies has revolutionized the treatment of HIV infection, significantly improving patient outcomes. However, these drugs can also have side effects, including hepatotoxicity, which can pose a significant challenge for patients. This research reviews the hepatotoxicity associated with contemporary antiretroviral drugs, focusing on data from recent years.

The Evolving Landscape of Antiretroviral Therapy: Balancing Efficacy and Safety

This research highlights the evolving landscape of antiretroviral therapies, with new drugs offering improved efficacy and safety profiles. The authors provide a comprehensive overview of the hepatotoxicity associated with contemporary antiretroviral drugs, emphasizing the need for careful monitoring and management. This research underscores the importance of staying current with the latest scientific evidence and making informed decisions regarding treatment options.

The Challenge of Hepatotoxicity: Navigating the Desert of HIV Treatment

This research highlights the importance of vigilant monitoring and careful management of hepatotoxicity in patients receiving antiretroviral therapy. The authors provide a comprehensive review of the hepatotoxicity associated with contemporary antiretroviral drugs, emphasizing the need for careful patient selection and informed decision-making. This research serves as a reminder that even with advancements in HIV treatment, there are still challenges to overcome. By staying informed and proactive, we can ensure the safety and well-being of patients living with HIV.

Dr.Camel's Conclusion

This research provides a valuable overview of the hepatotoxicity associated with contemporary antiretroviral drugs. The authors emphasize the importance of careful monitoring and management of this potential side effect. This research highlights the ongoing need for research and development of new antiretroviral therapies with improved safety profiles and minimal hepatotoxicity.
Date :
  1. Date Completed 2021-10-22
  2. Date Revised 2023-09-03
Further Info :

Pubmed ID

34545037

DOI: Digital Object Identifier

01222929-202111000-00002

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.